A comprehensive in vitro study demonstrated a strong dependency of BL cells on FoxO1 activity level, with both knockdown and inhibition (AS1842856; dosed at 40–80 nm) negatively impacting malignant B cell growth [106]. The gene discussed is FOXO1; the disease is Burkitt lymphoma.